Daily Archives: March 3, 2020

CNH Industrial fully supportive of Nikola Corporation NASDAQ listing

London, March 3, 2020

Today’s announcement of Nikola Corporation’s intended listing on the NASDAQ Exchange, New York, U.S.A. later this year, through its merger with VectoIQ, is fully supported by CNH Industrial N.V. (NYSE:CNHI / MI:CNHI).

“This is exciting news and another key milestone for our joint project to deliver zero emission Heavy-Duty Trucks and hydrogen infrastructure through a unique business model. Nikola’s NASDAQ listing gives further impetus to the ambitious targets we have set ourselves, to be at the forefront of scalable clean technology investments transforming our businesses and environment alike,” said Hubertus Mühlhäuser, Chief Executive Officer, CNH Industrial.

CNH Industrial entered into a strategic and exclusive Heavy-Duty Truck partnership with Nikola in September 2019 as the lead Series D investor, with a $250 million stake. IVECO and FPT Industrial, the commercial vehicle and powertrain brands of CNH Industrial, recently announced they will manufacture, through their European Joint Venture with Nikola Motor Company, the Nikola TRE, battery electric (BEV) Heavy-Duty Truck, at IVECO’s Ulm, Germany manufacturing site. Start of production is anticipated within the first half of 2021.

“Nikola’s unswerving ambition to comprehensively transform our industry and its environmental footprint represents a great non-cyclical growth path for the business. Listing at NASDAQ, in order to raise funds in today´s market environment, is clear recognition and support of the project’s strategic direction,” said Gerrit Marx, President Commercial and Speciality Vehicles, CNH Industrial.

CNH Industrial N.V. (NYSE: CNHI /MI: CNHI) is a global leader in the capital goods sector with established industrial experience, a wide range of products and a worldwide presence. Each of the individual brands belonging to the Company is a major international force in its specific industrial sector: Case IH, New Holland Agriculture and Steyr for tractors and agricultural machinery; Case and New Holland Construction for earth moving equipment; Iveco for commercial vehicles; Iveco Bus and Heuliez Bus for buses and coaches; Iveco Astra for quarry and construction vehicles; Magirus for firefighting vehicles; Iveco Defence Vehicles for defence and civil protection; and FPT Industrial for engines and transmissions. More information can be found on the corporate website: www.cnhindustrial.com

Nikola Corporation designs and manufactures hydrogen-electric vehicles, electric vehicle drivetrains, vehicle components, energy storage systems, and hydrogen stations. The company is bringing the nation’s most advanced semi-trucks to market with more than 14,000 trucks on preorder. Nikola is led by its visionary CEO Trevor Milton, who has assembled one of the most talented teams in the country to bring the Nikola products to market. The company is privately-held and headquartered in Arizona. For more information, visit nikolamotor.com

Sign up for corporate news alerts from the CNH Industrial Newsroom:
bit.ly/media-cnhindustrial-subscribe

Media contact:

Laura Overall
Corporate Communications Manager
CNH Industrial
Tel. +44 (0)2077 660 338
E-mail: mediarelations@cnhind.com
www.cnhindustrial.com

Attachment

 

Philips debuts new emergency care informatics suite in U.S. market at HIMSS 2020

March 3, 2020

  • Now with FDA 510(K) clearance, web-based dashboard supports real-time data transfer to empower clinical decision-making in emergency care
  • Enhanced bidirectional feedback between first responders in the field and clinicians in the hospital helps improve patient care

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the U.S. launch of its pre-hospital informatics solution to provide real-time, bidirectional feedback between emergency responders on the scene and doctors in the hospital awaiting the arrival of the patient. The combination of Philips’ rugged, advanced vital signs monitor and its new emergency care informatics web-based dashboard enables emergency teams to capture and transmit clinical data to remote specialists, allowing the team at the hospital to immediately review a patient’s vitals and plan for their arrival. The solution aims to help emergency responders provide the best care possible in unpredictable pre-hospital environments.

Evolving EMS role currently outpacing evolving technology
The role of Emergency medical services (EMS) has evolved drastically, as they now face both clinical and operational challenges in trying to address the needs of patients. Caregivers experience unpredictable workloads in uncontrolled situations with the expectation they will diagnose, treat and transport patients where necessary. Challenges are exacerbated by lagging technological advancements, particularly in relation to flexibility of use and data acquisition. Monitors and defibrillators are typically bulky and heavy, while data collection remains a predominantly manual and retrospective process. Data automation and more reliable communication capabilities, paired with smaller and lighter monitors, can empower emergency responders to provide care closer to home, avoid unnecessary transports, and better allocate resources, helping to achieve the quadruple aim of improved outcomes, enhanced satisfaction for caregivers and patients, and reduced costs.

“Emergency medical service personnel are increasingly sharing that the rising demands placed on first responders coupled with the challenging and diverse cases they see require improved technology to meet patient needs,” said Arman Voskerchyan, General Manager for Therapeutic Care at Philips. “Emergency care is no longer just about resuscitation – there are higher incidences of cardiovascular disease, increasing co-morbidities, and a rapidly growing aging population. With these changes, EMS providers need better access to data and resources to help them adapt and equip them with the information needed to save lives.”

Making its debut in the U.S. at HIMSS 2020, the solution has already been in use in Europe, helping care teams spot life-threatening conditions remotely, improve accuracy of support from on-scene crews, and enhance tailoring of in-hospital care based on pre-hospital physiology.

Philips Portfolio in Emergency Care
In October 2019, Philips announced a first-of-its-kind collaboration with Air Ambulance Kent Surrey Sussex (AAKSS) where helicopter Emergency Service (HEMS) teams were able to live stream patient medical information from the scene to the hospital through the Philips pre-hospital solution. Philips offers a range of emergency care offerings, including automated external defibrillators (AEDs), advanced life support monitors, and more.

For more information on Philips’ full portfolio of integrated smart enterprise systems, devices, software and services that will be spotlighted in Booth #2701 at the HIMSS Global Conference & Exhibition in Orlando, FL, Mar. 9 -13, 2020, visit www.philips.com/himss and follow @PhilipsLiveFrom for #HIMSS2020 updates throughout the event.

For further information, please contact:

Kathy O’Reilly
Philips Global Press Office
Tel.: +1 978-221-8919
E-mail: kathy.oreilly@philips.com
Twitter: kathyoreilly

Silvie Casanova
Philips North America
Tel: +1 781-879-0692
Email: Silvie.casanova@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

 

Advantest Conducting Virtual Tradeshow on March 10-11 to Continue Flow of IC Testing Info Despite Coronavirus Situation

Online Event to Feature Presentations on the Newest Semiconductor Testing Advances and Market Outlook by Advantest and SEMI Speakers

TOKYO, March 03, 2020 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) is organizing a virtual tradeshow on March 10-11 to share valuable technical and market data with its customers worldwide without risking attendees’ exposure to potential illness from the coronavirus (COVID-19).

Using web conferencing, technical experts from Advantest will present the newest semiconductor-testing technologies and best practices as well as interact with strategic partners, current and potential customers.  In addition, the online forum will feature talks on the state of the industry and the market outlook from two senior executives of SEMI, the global industry organization representing the electronics-manufacturing supply chain.

“We developed this virtual tradeshow to promote awareness of today’s most advanced semiconductor test solutions despite the cancellation of many industry tradeshows and conferences due to the tragic coronavirus outbreak,” said Judy Davies, vice president of global marketing communications for Advantest.  “As we work to support our customers by sharing timely and relevant information through an international event, it is very appropriate to have SEMI take part and provide their insights as well.”

“SEMI is excited to participate in this virtual trade show as Advantest turns to online communications to ensure the safety of attendees and maintain the free flow of advantageous information via key industry insights to our members worldwide,” said Ajit Manocha, president and CEO of SEMI.

On March 10 and 11, Advantest’s innovative virtual tradeshow will feature presentations by an international array of nine speakers sharing their expert insights in various languages.  To promote the broadest use of the information presented, sessions will be presented in English, Mandarin Chinese and Korean.

Each session will be interactive, providing audience members with opportunities to ask questions.  All sessions will be recorded and posted online for continued reference following the two-day event.

The agenda for the virtual tradeshow is:

Tuesday, March 10
8:00 a.m. Pacific Daylight Time (PDT)
Standalone (SA) & Non-Standalone (NSA) 5G NR Device Testing: MIMO and Carrier Aggregation (in English)
Dinesh Doshi, President, W2BI, an Advantest Group Company

5:00 p.m. PDT
Welcome and Overview (in English)
Judy Davies, Vice President of Global Marketing Communications, Advantest

5:30 p.m. PDT
SEMI Update (in English)
Ajit Manocha, President and CEO, SEMI

6:00 p.m. PDT
SEMI Market Outlook:  Fab Investment, Equipment/Material Markets and New Asia Supply Chain (in English)
Clark Tseng, Director of Industry Research and Statistics, SEMI

6:30 p.m. PDT
5G NR Semiconductor Test Challenges (in English)
Sungjong Park, RF Test Engineer/Manager, Advantest Korea

7:00 p.m. PDT
Test Cell Management for Enabling Smart Manufacturing (in English)
Kyoungyong Kang, SoC UI Team Lead, Advantest Korea

7:30 p.m. PDT
Driving for Perfection: Finding the Optimum Test Solution for Next-Generation Automotive ICs (in English)
Masashi Nagai, Senior Executive Director, Strategic Planning Group, Advantest Korea

8:00 p.m. PDT
Low-Cost Solution for Ultra-High-Speed SerDes to RF Communication Test Via Onboard FPGA (in English)
Tang Mingjie, Application Engineer, Advantest China

8:15 p.m. PDT
A Programming Framework of Concurrent Test on SmarTest 7 for IPs That Share the Same Access Port (in English)
Tianyu Zhang, Application Engineer, Advantest China

8:30 p.m. PDT
Closing Remarks (in English)
Judy Davies, Vice President of Global Marketing Communications, Advantest

Wednesday, March 11
6:00 p.m. PDT
Welcome and Overview (in English)
Judy Davies, Vice President of Global Marketing Communications, Advantest

6:30 p.m. PDT
5G NR Semiconductor Test Challenges (in Korean)
Sungjong Park, RF Test Manager, Advantest Korea

7:00 p.m. PDT
Test Cell Management for Enabling Smart Manufacturing (in Korean)
Kyoungyong Kang, SoC UI Team Lead, Advantest Korea

7:30 p.m. PDT
Driving for Perfection: Finding the Optimum Test Solution for Next-Generation Automotive ICs (in English)
Masashi Nagai, Senior Executive Director, Strategic Planning Group, Advantest Korea

8:00 p.m. PDT
Low-Cost Solution for Ultra-High-Speed SerDes to RF Communication Test Via Onboard FPGA (in Chinese)
Tang Mingjie, Application Engineer, Advantest China

8:15 p.m. PDT
A Programming Framework of Concurrent Test on SmarTest 7 for IPs That Share the Same Access Port (in Chinese)
Tianyu Zhang, Application Engineer, Advantest China

Advantest employees, customers, prospective customers and partners are invited to connect with each other through this two-day virtual tradeshow.

How to Attend

All sessions will be streamed. It is recommended that you listen to the audio via your computer speakers using the links below instead of via phone.

W2BI session on March 10 at 8 am PDT:

All March 10 sessions from 5 pm – 9 pm PDT:

All March 11 sessions from 6 pm – 8:30 pm PDT:

Webcast Access Instructions

Use the links above to pre-register for each session and receive a calendar file via email. For optimal viewing, it is best to connect directly to the Internet and not use VPN. Also, disable your pop-up blockers to view the content in its entirety. Test your connection prior to joining. Connection Test: Click Here. For system requirements, visit the FAQ.

Social Media
For all the latest news from the leader in test solutions, follow Advantest on Twitter @Advantest_ATE.

About Advantest Corporation
Advantest (TSE: 6857) is the leading manufacturer of automatic test and measurement equipment used in the design and production of semiconductors for applications including 5G communications, the Internet of Things (IoT), autonomous vehicles, artificial intelligence (AI), machine learning, smart medical devices and more.  Its leading-edge systems and products are integrated into the most advanced semiconductor production lines in the world.  The company also conducts R&D to address emerging testing challenges applications, produces multi-vision metrology scanning electron microscopes essential to photomask manufacturing, and offers groundbreaking 3D imaging and analysis tools.  Founded in Tokyo in 1954, Advantest is a global company with facilities around the world and an international commitment to sustainable practices and social responsibility.  More information is available at www.advantest.com.

ADVANTEST CORPORATION
3061 Zanker Road
San Jose, CA 95134, USA
Judy Davies
Judy.davies@advantest.com

Quanta Publishes Study in PLOS ONE: Enhancement of Solute Clearance using Pulsatile Push-Pull Dialysate Flow for SC+

Quanta Publishes Study in PLOS ONE:
Enhancement of Solute Clearance using Pulsatile Push-Pull Dialysate Flow for SC+

Alcester, Warwickshire, UK, 03 March 2020: Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a British medical technology innovation company, today announces that the peer-reviewed scientific journal PLOS ONE has published results from the Company’s investigations into a possible future development concept for its personal haemodialysis platform SC+. The publication reports on an ex vivo feasibility study showing enhancement of solute clearance using an experimental mode for pulsatile push-pull dialysate flow in a prototype variant of the SC+ device. This establishes feasibility that SC+ is potentially capable of delivering a therapy comparable to haemodiafiltration (HDF) without introducing additional complexity to the user.

Haemodialysis (HD) is based on diffusive clearance and is generally accepted as the standard of care for renal replacement therapy. HDF has been developed as an alternative form of therapy that adds convective flows to improve middle-molecular-weight clearance. Several studies suggest there may be clinical benefits to HDF; however, the additional complexity of managing an HDF treatment can create barriers making it burdensome for in-centre patients and inaccessible to self-care and home patients.

For this study, Quanta developed a prototype variant of SC+ that delivers convective flows equivalent to HDF without introducing any additional complexity to the user. Results from the study show that the pumping action generated by the prototype SC+ produced an enhancement of middle-molecular-weight clearance comparable with that achieved using
pre-dilution HDF. Further studies are required to optimise device settings, but initial results show that SC+ has the potential to increase patients’ freedom of therapy choice without introducing additional complexity to their treatment.

Professor Clive Buckberry, Chief Technology Officer, commented: “We are pleased to announce the publication of this study in PLOS ONE. The results not only establish the feasibility that SC+ could deliver a therapy comparable to HDF, but also further demonstrate the versatility of SC+ for self-care and home haemodialysis applications.”

John E. Milad, Chief Executive Officer, added: “Although this is only a feasibility study, it clearly demonstrates the exciting potential for SC+ to address future applications and additional clinical needs.”

The full paper entitled ‘Enhancement of solute clearance using pulsatile push-pull dialysate flow for the Quanta SC+: a novel clinic-to-home haemodialysis system’ is available online here: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0229233

-ENDS-
For more information about Quanta, please contact:

 

Quanta
John E. Milad,
Chief Executive Officer

T: +44 (0)1789 400043
E: enquiries@quantadt.com
Consilium Strategic Communications
Amber Fennell / Matthew Neal / Lindsey Neville
T: +44 (0)203 709 5708
E: quanta@consilium-comms.com

About Quanta and SC+
Quanta is a technology-enabled solutions provider based in the UK that aims to improve the lives of dialysis patients through beautifully engineered innovation. Quanta’s lead product SC+ is designed to empower dialysis patients by giving them greater freedom, convenience and control over the delivery of their life-sustaining therapy.

SC+ is a small and simple-to-use haemodialysis system designed to empower patients to manage their dialysis therapy, providing greater flexibility around where, when and how to dialyse. As a CE marked medical device, SC+ has been successfully piloted with the NHS, demonstrating clinical efficacy and performance compatible with traditional treatment regimens used in-centre. The innovative and patented technology behind SC+ is based on a design breakthrough that allows all dialysate fluid management to be conducted on a small, lightweight, disposable cartridge. The small form factor and intuitive design are intended to enable a broader range of users—including patients themselves—to manage dialysis therapy delivery across a wide range of settings, from the clinic to the home, without compromising on performance.  SC+ is designed to work with the Internet-of-Things through a propriety cloud-based digital health offering.

For more information, please visit our website: quantadt.com.

SC+ is not yet FDA cleared and not yet available for sale in the USA.

 

Dr. D.Y. Patil Hospital & Research Centre Selects Juniper Networks to Power World-Class, Tech-Enabled Healthcare in India

Sophisticated network upgrades engineers simplicity and automation across the hospital’s digitization efforts, streamlining availability of systems such as the EHR, HIS and PACS

BANGALORE, India and PUNE, India, March 03, 2020 (GLOBE NEWSWIRE) — Juniper Networks, a leader in secure, AI-driven networks, today announced that it has been selected by the Dr. D.Y. Patil Hospital & Research Centre in Pune, one of Asia’s leading medical institutes1, for its network upgrade. This will greatly simplify the hospital’s network configuration, management and maintenance and allow it to deliver world-class, technology-enabled healthcare with zero downtime.

Founded in 1996, the fast-growing Dr. D.Y. Patil Vidyapeeth University (DPU) has developed into a large network that encompasses nine medical and teaching institutions. The state-of-the-art, multi-specialty hospital in Pune itself stretches across 725,000 square feet, with provision for over 2000 beds, 13 basic outpatient departments (OPD), eight super-specialty OPDs and 31 operation theatres.

In line with the country’s push toward a Digital India, DPU was seeking a cost-effective and easy-to-manage network upgrade that could accommodate the healthcare industry’s rapid digital transformation. The requirements included the ability to not only support, but also futureproof the hospital’s digitization efforts, especially with initiatives such as the electronic health record system (EHR), picture archival and communications system (PACS) and the hospital information system (HIR).

Juniper Networks was selected for its ability to deliver a resilient, secure and highly automated architecture that could operate 24×7 with 100 percent uptime, while still allowing for scalability alongside the growth of the institute. This solution framework was crucial for significant improvements in treatment and recovery time, without negatively impacting the performance and availability of other critical healthcare applications.

Across a sophisticated network infrastructure, DPU has deployed comprehensive upgrades from Juniper, including the QFX5100 and EX4600 switches, while implementing an inside-out security model through Juniper Connected Security by deploying the SRX1500 services gateway. In addition, the Junos Space network management platform has allowed the small IT team to automate policies, configurations, change management and troubleshooting – all from a central location.

Since the Juniper Networks deployment, D.Y. Patil Hospital & Research Centre has seen 100 percent availability and an increase in network performance by over 60 percent. With Juniper’s proven network automation capabilities, the entire institute is now managed by only two engineers who supervise over 5000+ IT users across the campus.

_________
1 Awarded at the 9th Asian Education Summit and Awards, April 2019 (New Delhi)

News Highlights

  • The EX4600 switches at the campus core are connected to DPU’s datacenter situated at its head office, which has QFX5100 switches at the datacenter’s core.
  • As a part of the Juniper Connected Security solution, the SRX1500 services gateway alongside the Juniper Advanced Threat Protection Appliance were integrated into the network, to ensure an inside-out security model securing both N-S and E-W traffic across the network.
  • Junos Space tied everything together and provided centralized management, allowing the small IT team to easily automate policies, configurations, change management and troubleshooting.

Supporting Quotes

“DPU’s world-class Dr. D.Y. Patil Hospital & Research Centre situated at Pimpri, Pune is a prime example of how network infrastructure in the Indian healthcare sector needs revamping in order to stay vigilant and agile, without compromising on patient experience and customer accessibility. We’re thrilled to have been selected by DPU to provide our state-of-the-art networking and security solution. We see this as a benchmark for secure and efficient IT infrastructure across the healthcare ecosystem, and are committed to continued transformation alongside a Digital India.”

      –      Sajan Paul, Managing Director and Country Manager, India and SAARC, Juniper Networks, India

“What we have built alongside Juniper Networks at the D.Y. Patil Hospital & Research Centre is a true example of medical advancement. As a healthcare institution, our reliance on a reliable network infrastructure is especially critical. Having made the transformation into paperless, digitized systems, any downtime would severely hamper the course of treatment or restrict access to information. With the network upgrades, our robust, automated and scalable infrastructure today has allowed for 100 per cent uptime, with the ability to constantly adapt. We are delighted to have grown our infrastructure with the assistance of Juniper Networks over a long-term partnership, and we look forward to the continued build-up of a world-class healthcare ecosystem for many years to come.”

      –      Dr. Somnath P. Patil, Secretary, Dr. D.Y. Patil Vidyapeeth Society

About Juniper Networks

Juniper Networks challenges the inherent complexity that comes with networking in the multicloud era. We do this with products, solutions and services that transform the way people connect, work and live. We simplify the process of transitioning to a secure and automated multicloud environment to enable secure, AI-driven networks that connect the world. Additional information can be found at Juniper Networks (www.juniper.net), or connect with Juniper on TwitterLinkedIn and Facebook.

Juniper Networks, the Juniper Networks logo and Junos are registered trademarks of Juniper Networks, Inc.  It is affiliated in the United States and other countries. Other names may be trademarks of their respective owners.

Media Contact:
Kenneth Chew
Juniper Networks
+65 65113529
kchew@juniper.net